REQUEST A DEMO
Total
USD $0.00
Search more companies

Central Luzon Drug Corp. (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Central Luzon Drug Corp. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Central Luzon Drug Corp. is a company in Philippines, with a head office in Quezon City. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Central Luzon Drug Corp. was incorporated on December 07, 1994. Central Luzon Drug Corp. currently employs 700 (estimated) people. The latest financial highlights indicate a net sales revenue increase of 8.65% in 2023. Its’ total assets recorded a growth of 1.56%. The enterprise’s net profit margin increased by 0.07% in 2023.

Headquarters
7 Richmond Avenue, Bagumbayan
Quezon City; National Capital Region; Postal Code: 1110

Contact Details: Purchase the Central Luzon Drug Corp. report to view the information.

Basic Information
Total Employees:
Purchase the Central Luzon Drug Corp. report to view the information.
Financial Auditors:
Purchase the Central Luzon Drug Corp. report to view the information.
Incorporation Date:
December 07, 1994
Key Executives
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Central Luzon Drug Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
8.65%
Total Operating Revenue
8.65%
Operating Profit
16.49%
EBITDA
16.49%
Net Profit/Loss for the Period
16.98%
Total Assets
1.56%
Total Equity
14.08%
Operating Profit Margin
0.09%
Net Profit Margin
0.07%
Return on Equity (ROE)
-3.97%
Debt / Equity
-20.9%
Quick Ratio
0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?